SCHEMBL624667

SCHEMBL624667

O=C1CCOC(=Cc2cccnc2)C1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.53
SMN1; SMN2 Q16637 7/20 0.50
RAB9A P51151 5/20 0.50
HTT P42858 4/20 0.50
ATM Q13315 2/20 0.50
MAOB P27338 1/20 0.45
ALDH1A1 P00352 4/20 0.44
KMT2A Q03164 3/20 0.44
CYP19A1 P11511 3/20 0.44
MEN1 O00255 2/20 0.44
MIF P14174 1/20 0.44
PKM P14618 1/20 0.44
LMNA P02545 4/20 0.43
MITF O75030 3/20 0.43
NPC1 O15118 1/20 0.43
NSD2 O96028 1/20 0.43
MAPK1 P28482 1/20 0.43
GSK3B P49841 1/20 0.43
STK17B O94768 1/20 0.42
CYP11B1 P15538 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL625589 0.81 MAPK1 (0.45) MAPTSMN1; SMN2RAB9AHTTMAOB
SCHEMBL28575414 0.81 ALDH1A1 (0.56) MAPTHTTMAOBALDH1A1KMT2A
SCHEMBL28575415 0.81 ALDH1A1 (0.56) MAPTHTTMAOBALDH1A1KMT2A
SCHEMBL625784 0.72 KMT2A (0.57) RAB9AMAOBALDH1A1KMT2AMEN1
SCHEMBL624231 0.72 MAPK1 (0.45) MAPTSMN1; SMN2RAB9AHTTATM
SCHEMBL28571361 0.72 MAPT (0.54) MAPTSMN1; SMN2RAB9AHTTATM
SCHEMBL28587113 0.70 EGFR (0.50) MAPTRAB9AATMMAOBALDH1A1
SCHEMBL28587111 0.70 EGFR (0.50) MAPTRAB9AATMMAOBALDH1A1
SCHEMBL625559 0.70 MAOB (0.42) MAPTSMN1; SMN2RAB9AHTTMAOB
SCHEMBL30852828 0.69 MAPT (1.00) MAPTSMN1; SMN2RAB9AHTTATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012021692-A1 CURCUMIN ANALOGS AND METHODS OF USE THEREOF RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2012-02-16 WO disclosed